Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Merck
McKinsey
Moodys
Express Scripts

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR AZELASTINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Azelastine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00561717 ↗ A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis Completed Kingston General Hospital Phase 4 2007-10-01 Finding out how fast azelastine nasal spray works in subjects with hay fever.
NCT00561717 ↗ A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis Completed Kingston Health Sciences Centre Phase 4 2007-10-01 Finding out how fast azelastine nasal spray works in subjects with hay fever.
NCT00561717 ↗ A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis Completed Bayer Phase 4 2007-10-01 Finding out how fast azelastine nasal spray works in subjects with hay fever.
NCT00612118 ↗ A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis Completed GlaxoSmithKline Phase 2 2008-02-01 This study is an 8 day, randomised, double blind, 2-way crossover trial of repeat doses of intranasal GSK256066 and azelastine hydrochloride in the Vienna Challenge Chamber in subjects with seasonal allergic rhinitis (SAR). Laboratory safety assessments, 12-lead electrocardiograph (ECG), vital signs and adverse event enquiries will be made throughout the study. Nasal examination, symptom scores, and allergen challenge assessments will also be performed at various time points throughout the study.
NCT00651118 ↗ A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies Completed Meda Pharmaceuticals Phase 3 2008-03-01 The purpose of this study is to determine if two allergy medications (azelastine and fluticasone) are more effective than placebo or either medication alone (azelastine or fluticasone)
NCT00660517 ↗ A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies Completed Meda Pharmaceuticals Phase 3 2007-12-01 The purpose of this study is to determine if two allergy medications (azelastine and fluticasone) are more effective than placebo or either medication alone (azelastine or fluticasone)
NCT00660829 ↗ A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies Completed Meda Pharmaceuticals Phase 3 2007-12-01 The Purpose of this study is to determine if one allergy medication (0.15% azelastine hydrochloride) is more effective than Placebo alone.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Azelastine Hydrochloride

Condition Name

Condition Name for Azelastine Hydrochloride
Intervention Trials
Seasonal Allergic Rhinitis 19
Allergic Rhinitis 12
Perennial Allergic Rhinitis 2
Allergy 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Azelastine Hydrochloride
Intervention Trials
Rhinitis 39
Rhinitis, Allergic 38
Rhinitis, Allergic, Seasonal 21
Rhinitis, Allergic, Perennial 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Azelastine Hydrochloride

Trials by Country

Trials by Country for Azelastine Hydrochloride
Location Trials
United States 160
Canada 6
Germany 2
United Kingdom 2
Turkey 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Azelastine Hydrochloride
Location Trials
Texas 14
Pennsylvania 9
New Jersey 8
Colorado 8
California 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Azelastine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Azelastine Hydrochloride
Clinical Trial Phase Trials
Phase 4 16
Phase 3 15
Phase 2 5
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Azelastine Hydrochloride
Clinical Trial Phase Trials
Completed 27
Unknown status 5
Not yet recruiting 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Azelastine Hydrochloride

Sponsor Name

Sponsor Name for Azelastine Hydrochloride
Sponsor Trials
Meda Pharmaceuticals 11
MEDA Pharma GmbH & Co. KG 4
Alcon Research 3
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Azelastine Hydrochloride
Sponsor Trials
Industry 34
Other 27
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.